Raabta Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 01-06-2024
- Paid Up Capital ₹ 0.50 M
as on 01-06-2024
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 4.03 M
as on 01-06-2024
- Revenue 4810.10%
(FY 2021)
- Profit -9.61%
(FY 2021)
- Ebitda 38.62%
(FY 2021)
- Net Worth -206.29%
(FY 2021)
- Total Assets 82.33%
(FY 2021)
About Raabta Pharma
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹4.03 M.
Pusati Reddy and Gudelli Patak serve as directors at the Company.
- CIN/LLPIN
U24236TG2018PTC126275
- Company No.
126275
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Aug 2018
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Raabta Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pusati Reddy  | Director | 23-Aug-2018 | Current |
| Gudelli Patak | Director | 23-Aug-2018 | Current |
Financial Performance of Raabta Pharma.
Raabta Pharma Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 4810.1% increase. The company also saw a slight decrease in profitability, with a 9.61% decrease in profit. The company's net worth observed a substantial decline by a decrease of 206.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Raabta Pharma?
In 2021, Raabta Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
City Union Bank Limited Creation Date: 10 Aug 2021 | ₹4.03 M | Open |
How Many Employees Work at Raabta Pharma?
Unlock and access historical data on people associated with Raabta Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Raabta Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raabta Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
